Torrent Pharmaceuticals Limited has informed the Exchange regarding voting results of Court Convened General Meeting held on April 28, 2026

Scheme filed with the NCLTStrategic Transactions View source PDF Explain this filing

TORNTPHARM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.8%Reaction day

₹4186.10

prior close

₹4220.00

announcement price

After-mkt

timing

Nifty 100market · index membership as recorded later (tracked since Jun 2026)+0.6%+0.2% vs market

Pharmaceuticals peers, median of 165sector+0.0%+0.8% vs sector

On the reaction day the stock moved 0.2 pts more than Nifty 100 and 0.8 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.1

10m

+0.3

15m

+0.6

30m

+1.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.8+0.6+0.2+0.0+0.8

Next day

+0.1-0.2+0.4-0.5+0.6

+1.8+0.3+1.5+0.0+1.8

+2.5+0.1+2.3+0.5+1.9

+4.1+1.4+2.6+2.3+1.8

+4.0+1.5+2.5+3.0+0.9

+7.9-0.7+8.6+3.2+4.7

15d

+6.9-1.4+8.3+2.4+4.5

+5.5-1.4+6.9+3.8+1.7

+10.9+0.1+10.9+4.8+6.1

+16.5+1.4+15.1+7.1+9.5

UpDownMarket · Nifty 100Sector · Pharmaceuticals peers, median of 165Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Torrent Pharmaceuticals Limited shareholders have approved the Scheme of Amalgamation of J.B. Chemicals & Pharmaceuticals Limited (JB Pharma) into Torrent Pharma. The NCLT-convened meeting held on April 28, 2026 approved the merger with 100% valid votes in favor. Total valid votes polled were approximately 31.5 crore shares worth Rs 1,575 crore, with only 341 votes (0%) against the resolution. Promoter shareholders (100% in favor) and 99.33% of public shareholders voted in favor. The scheme was passed by the requisite majority as required under Section 230(6) of the Companies Act.

Likely market impact

This is a significant acquisition for Torrent Pharma as it absorbs JB Pharma, a listed pharmaceutical company. The merger will expand Torrent Pharma's product portfolio and market presence. Shareholders should monitor for regulatory approvals and the final swap ratio announcement.